These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30103342)

  • 21. Huntington's disease: clinical characteristics, pathogenesis and therapies.
    Nakamura K; Aminoff MJ
    Drugs Today (Barc); 2007 Feb; 43(2):97-116. PubMed ID: 17353947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes of Potential Participants Towards Molecular Therapy Trials in Huntington's Disease.
    Bardakjian TM; Naczi KF; Gonzalez-Alegre P
    J Huntingtons Dis; 2019; 8(1):79-85. PubMed ID: 30689592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive Attitudes and Therapeutic Misconception Around Hypothetical Clinical Trial Participation in the Huntington's Disease Community.
    Cotter K; Siskind CE; Sha SJ; Hanson-Kahn AK
    J Huntingtons Dis; 2019; 8(4):421-430. PubMed ID: 31594242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell transplantation for Huntington's disease Should we continue?
    Dunnett SB; Rosser AE
    Brain Res Bull; 2007 Apr; 72(2-3):132-47. PubMed ID: 17352937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial on Clinical Trial's Corner.
    Thompson L; Leavitt BR
    J Huntingtons Dis; 2018; 7(1):87. PubMed ID: 29504545
    [No Abstract]   [Full Text] [Related]  

  • 26. An update on Huntington's disease: from the gene to the clinic.
    Kim SD; Fung VS
    Curr Opin Neurol; 2014 Aug; 27(4):477-83. PubMed ID: 24978638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on Huntington's disease: advances in care and emerging therapeutic options.
    Zielonka D; Mielcarek M; Landwehrmeyer GB
    Parkinsonism Relat Disord; 2015 Mar; 21(3):169-78. PubMed ID: 25572500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor outcome measures in Huntington disease clinical trials.
    Reilmann R; Schubert R
    Handb Clin Neurol; 2017; 144():209-225. PubMed ID: 28947119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular therapeutic strategies for Huntington's disease].
    Milewski M; Hoffman-Zacharska D; Ball J
    Postepy Biochem; 2015; 61(1):18-24. PubMed ID: 26281350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evidence-based approach in the treatment of Huntington's disease.
    Mestre TA; Ferreira JJ
    Parkinsonism Relat Disord; 2012 May; 18(4):316-20. PubMed ID: 22177624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are immunotherapies for Huntington's disease a realistic option?
    Denis HL; Lauruol F; Cicchetti F
    Mol Psychiatry; 2019 Mar; 24(3):364-377. PubMed ID: 29487401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the treatment options for Huntington's disease.
    Bonelli RM; Hofmann P
    Expert Opin Pharmacother; 2004 Apr; 5(4):767-76. PubMed ID: 15102562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic advances in Huntington's Disease.
    Shannon KM; Fraint A
    Mov Disord; 2015 Sep; 30(11):1539-46. PubMed ID: 26226924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Strategies for mutant gene expression silencing in Huntington’s disease therapy].
    Fiszer A; Nowak B
    Postepy Biochem; 2020 Mar; 66(1):1-9. PubMed ID: 33320475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Music therapy in Huntington's disease: a protocol for a multi-center randomized controlled trial.
    van Bruggen-Rufi M; Vink A; Achterberg W; Roos R
    BMC Psychol; 2016 Jul; 4(1):38. PubMed ID: 27457568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of neuronal death in Huntington's disease. First part: general considerations and histopathological features].
    Bantubungi K; Blum D
    Rev Med Brux; 2007; 28(5):413-21. PubMed ID: 18069515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How the gene behind Huntington's disease could be neutralized.
    Drew L
    Nature; 2018 May; 557(7707):S39-S41. PubMed ID: 29844556
    [No Abstract]   [Full Text] [Related]  

  • 38. Design optimization for clinical trials in early-stage manifest Huntington's disease.
    Frost C; Mulick A; Scahill RI; Owen G; Aylward E; Leavitt BR; Durr A; Roos RAC; Borowsky B; Stout JC; Reilmann R; Langbehn DR; Tabrizi SJ; Sampaio C;
    Mov Disord; 2017 Nov; 32(11):1610-1619. PubMed ID: 28906031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addressing the Value of Multidisciplinary Clinical Care in Huntington's Disease: A Snapshot of a New Huntington's Disease Center.
    Bardakjian TM; Klapper J; Carey A; Wood J; Pauly M; Gasper K; Lawler K; Tran B; Bell Y; Zwil A; Gonzalez-Alegre P
    J Huntingtons Dis; 2019; 8(4):501-507. PubMed ID: 31381522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
    Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
    J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.